This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Chubb Limited was formerly known as ACE Limited. ACE Limited after acquiring The Chubb Corp in Jan 2016 assumed the name of Chubb. Headquartered in Zurich, Switzerland, the company boasts being one of the world’s largest providers of property and casualty (P&C) insurance and reinsurance and largest publicly traded P&C insurer, based on market capitalization of $56.9 billion. Chubb has diversified through acquisitions into many specialty lines, including marine, medical risk, excess property, environmental and terrorism insurance and has local operations in 54 countries and territories. Chubb provides specialized insurance products such as personal accident, supplemental health and life insurance to individuals in select countries. Its reinsurance operations include both P&C and life companies.
Chubb (CB) Beats Q3 Earnings Estimates
by Zacks Equity Research
Chubb (CB) delivered earnings and revenue surprises of 16.02% and 1.56%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for These 3 Insurance Stocks in Q3 Earnings?
by Sushmita Sarker
Here, we take a look at three insurance stocks, UNM, CB and SKWD, which are set to report third-quarter earnings on Oct. 29.
Want Better Returns? Don?t Ignore These 2 Finance Stocks Set to Beat Earnings
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
The Zacks Analyst Blog Highlights Alphabet, UnitedHealth, Chubb, Key Tronic and Massimo
by Zacks Equity Research
Alphabet, UnitedHealth, Chubb, Key Tronic and Massimo are included in this Analyst Blog.
Chubb (CB) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Chubb (CB) concluded the recent trading session at $293.96, signifying a -0.35% move from its prior day's close.
Top Research Reports for Alphabet, UnitedHealth & Chubb
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), UnitedHealth Group Incorporated (UNH) and Chubb Limited (CB), as well as two micro-cap stocks Key Tronic Corporation (KTCC) and Massimo Group (MAMO).
Chubb (CB) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
by Zacks Equity Research
Beyond analysts' top -and-bottom-line estimates for Chubb (CB), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended September 2024.
Arch Capital Group (ACGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Arch Capital (ACGL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chubb Limited (CB) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Chubb (CB) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Can Chubb Limited Retain its Beat Streak This Earnings Season?
by Zacks Equity Research
CB's third-quarter results are likely to reflect higher premiums, driven by rate and exposure increases, and solid new business.
Chubb (CB) Expected to Beat Earnings Estimates: Should You Buy?
by Zacks Equity Research
Chubb (CB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chubb (CB) Stock Dips While Market Gains: Key Facts
by Zacks Equity Research
Chubb (CB) reachead $301.66 at the closing of the latest trading day, reflecting a -0.08% change compared to its last close.
W.R. Berkley Set to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
WRB's third-quarter results are likely to reflect higher premiums at both the segments, partially offset by higher expenses.
Why Investors Need to Take Advantage of These 2 Finance Stocks Now
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
NMIH vs. CB: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NMIH vs. CB: Which Stock Is the Better Value Option?
Chubb (CB) Outperforms Broader Market: What You Need to Know
by Zacks Equity Research
Chubb (CB) reachead $282.83 at the closing of the latest trading day, reflecting a +1.03% change compared to its last close.
Investors Heavily Search Chubb Limited (CB): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Chubb (CB). This makes it worthwhile to examine what the stock has in store.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Chubb (CB) Stock Slides as Market Rises: Facts to Know Before You Trade
by Zacks Equity Research
Chubb (CB) closed the most recent trading day at $291.33, moving -0.27% from the previous trading session.
Will Chubb (CB) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Chubb (CB) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
RenaissanceRe Adds Nearly $4B in Market Cap in 2024: Still a Buy?
by Zacks Equity Research
Despite being at its peak, RNR remains a compelling buy due to its solid cash position, favorable valuation and upward trend in earnings estimates.
Here is What to Know Beyond Why Chubb Limited (CB) is a Trending Stock
by Zacks Equity Research
Chubb (CB) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
The Zacks Analyst Blog Highlights Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products
by Zacks Equity Research
Toyota Motor, AstraZeneca, Chubb, Air T and Preformed Line Products are part of the Zacks top Analyst Blog.
Top Stock Reports for Toyota, AstraZeneca & Chubb
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Toyota Motor Corp. (TM), AstraZeneca PLC (AZN) and Chubb Ltd. (CB), as well as two micro-cap stocks Air T, Inc. (AIRT) and Preformed Line Products Co. (PLPC).
Chubb (CB) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
The latest trading day saw Chubb (CB) settling at $290, representing a -0.72% change from its previous close.